US Mental Health Spending Soars as More Americans Seek Treatment

RESEARCH TRIANGLE PARK, NC – March 19, 2026 – National spending on mental health and substance use disorder treatment has skyrocketed, surging from $40.9 billion in 2000 to $139.6 billion in 2021, according to a landmark study from RTI International and the Bureau of Economic Analysis. The analysis, published in Health Affairs, reveals a crucial insight: this dramatic increase was overwhelmingly driven by a substantial rise in the number of people receiving care, not by the cost of the care itself.

Increases in treated cases accounted for a remarkable 87% of the spending growth over two decades, with the rising cost per case contributing the remaining 13%. In 2021, treatment for mental health and substance use disorders constituted 5.5% of all medical spending in the United States, a significant slice of the nation's $4.3 trillion healthcare bill that year.

"Mental health and substance use disorders are major contributors to premature mortality in the United States, including deaths from suicide, drug overdoses, accidents and liver cirrhosis," said lead author Tami Mark, Ph.D., a Distinguished Fellow at RTI. "Understanding what the U.S. is spending on treating mental health and substance use disorders and what is driving spending growth is essential for policymakers and health systems working to improve access, quality and outcomes."

The Cost of Compassion: Policy Unlocks the Clinic Doors

The 241% surge in mental health and substance use spending significantly outpaced the 207% growth in overall U.S. healthcare expenditures during the same period. This indicates a specific and powerful shift in the behavioral health landscape, largely catalyzed by transformative federal legislation.

Two key policies served as the primary architects of this change: the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 and the Affordable Care Act (ACA) of 2010. Together, they systematically dismantled long-standing barriers that had placed mental healthcare out of reach for millions.

MHPAEA mandated that insurance coverage for mental health and substance use disorders be no more restrictive than coverage for physical health conditions. This forced insurers to eliminate inequitable co-pays, deductibles, and arbitrary limits on treatment sessions. The ACA built upon this foundation, designating mental and behavioral health services as an "Essential Health Benefit" for plans sold on its marketplaces. It also extended parity protections to millions more Americans and prohibited insurers from denying coverage based on pre-existing conditions, a common practice that had locked many with chronic mental health needs out of the system.

These policy changes effectively unlocked access, turning latent demand for care into active treatment. The study's finding that a higher volume of patients, rather than higher prices, fueled the spending boom is a direct reflection of this expanded access. For the first time, insurance coverage was available and robust enough to support sustained treatment for conditions that were previously managed with out-of-pocket payments, if at all.

Beyond the Stigma: A New Era of Diagnosis and Acceptance

While policy opened the door, profound societal shifts encouraged more people to walk through it. The two-decade period covered by the study saw a gradual but significant erosion of the stigma surrounding mental illness. Increased public awareness campaigns, celebrity disclosures, and a growing cultural conversation have made seeking help a less daunting prospect.

The study highlights that this trend was not uniform across all conditions. Treatment for mood disorders remained the largest single category of spending, but anxiety disorders and attention-deficit/hyperactivity disorder (ADHD) saw some of the fastest growth in per capita spending. This points to a greater recognition and willingness to treat conditions that were once minimized or misunderstood.

The rise in ADHD diagnoses, particularly among adults, has been dramatic. Experts attribute this to a confluence of factors, including reduced stigma, greater professional awareness of how ADHD presents in adults, and even the societal disruptions of the COVID-19 pandemic, which caused many to re-evaluate their cognitive and mental functioning. For many adults, seeing the condition in their own children has led to a moment of self-recognition.

Meanwhile, substance use disorders saw the greatest growth in the number of treated cases. This is strongly tied to the insurance expansions under the ACA and MHPAEA, which made residential treatment, medication-assisted therapies, and long-term counseling financially viable for a much larger population grappling with addiction.

The Next Frontier: Measuring What Truly Matters

As the nation invests more heavily in behavioral health, the study sounds a critical note of caution, underscoring the urgent need for stronger data systems to connect treatment with long-term outcomes. The central question is shifting from how many people are being treated to how well they are being treated.

Currently, the mental healthcare sector lags significantly behind physical medicine in adopting value-based care models, which tie financial reimbursement to proven patient outcomes. Measuring success in mental health is inherently complex; recovery is often a non-linear, long-term process involving subjective improvements in quality of life, functioning, and well-being, which are difficult to capture in claims data.

This data gap presents a major challenge. Without robust outcome measurement, it's difficult for policymakers and health systems to determine which treatments provide the best value or to hold providers accountable for the quality of care. Experts in health economics express concern that simply increasing spending without a parallel focus on effectiveness is unsustainable and may not lead to the population-level improvements desired.

The path forward, as suggested by the study and echoed by leaders in the field, involves a concerted push toward a new infrastructure for accountability. This includes the widespread adoption of patient-reported outcomes (PROs), where patients regularly provide feedback on their symptoms and functioning, and the development of data systems that can track these metrics over time. By focusing on what matters most to the people receiving care, the healthcare system can begin to ensure that its historic investment in mental health translates into meaningful, lasting recovery.